FDA label
What is Pomalyst used for?
Pomalyst contains pomalidomide. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label for Pomalyst lists 2 uses: Multiple Myeloma; Kaposi Sarcoma.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Pomalyst?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Pomalyst, capsule
Indications and Usage, quoted from the label by Celgene Corporation (NDA204026). Cross-references to other label sections are left out.
Multiple Myeloma
POMALYST, in combination with dexamethasone, is indicated for adult patients with multiple myeloma (MM) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy.
Kaposi Sarcoma
POMALYST is indicated for the treatment of:
- Adult patients with AIDS-related Kaposi sarcoma (KS) after failure of highly active antiretroviral therapy (HAART).
- Kaposi sarcoma (KS) in adult patients who are HIV-negative.
This indication is approved under accelerated approval based on overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).
Source: DailyMed label, set id 2b25ef01-5c9e-11e1-b86c-0800200c9a66, version 26, effective February 26, 2025. NDC 59572-501, one of 4 listings for this product.
Questions
What is Pomalyst used for?
The FDA label for Pomalyst lists 2 uses: Multiple Myeloma; Kaposi Sarcoma.
What drug class is Pomalyst?
FDA lists pomalidomide in the Thalidomide Analog established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.